Neil Herskowitz is Director at AVENUE THERAPEUTICS, INC. (ATXI). They have made 21 open-market trades across 5 companies since 2006, most recently 2026-07-01.
CIK 0001298246
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
19 open-market purchases totalling $504K since 2006, against 2 sales. Across 15 scored buys the stock is down 4.4% at ninety days, and 8.2 points behind the S&P over the same stretch.
15 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 40% | 33% | 47% |
| Avg Move | -6.0% | -4.8% | -4.4% |
| Alpha | -4.2% | -3.2% | -8.2% |
| Scored | 15 | 15 | 15 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MBIO | SELL | 2025-12-30 | 2025-12-30 | $0.96 | $237 | +16.8% | +2.2% | -21.7% |
| ATXI | SELL | 2024-12-02 | 2024-12-03 | $2.00 | $46 | -4.3% | +2.7% | -46.3% |
| ATXI | BUY | 2021-05-06 | 2021-05-07 | $3.99 | $10K | +1.6% | +1.1% | -60.7% |
| ATXI | BUY | 2020-02-26 | 2020-03-02 | $8.23 | $21K | -17.6% | -1.9% | +26.7% |
| ATXI | BUY | 2020-02-25 | 2020-02-25 | $9.31 | $93K | -6.9% | -16.0% | +15.6% |
| ATXI | BUY | 2019-06-17 | 2019-06-19 | $5.86 | $29K | +6.8% | +8.4% | +5.8% |
| ATXI | BUY | 2019-04-15 | 2019-04-15 | $4.52 | $5K | +8.1% | +2.7% | +34.9% |
| ATXI | BUY | 2019-03-28 | 2019-03-29 | $5.11 | $10K | +4.9% | +2.8% | +28.5% |
| ATXI | BUY | 2019-02-25 | 2019-02-25 | $5.46 | $27K | +1.9% | -5.7% | -9.3% |
| ATXI | BUY | 2019-02-04 | 2019-02-06 | $5.88 | $52K | +0.2% | -10.7% | -24.9% |
| ATXI | BUY | 2019-01-30 | 2019-02-01 | $5.91 | $4K | -1.2% | -6.2% | -23.9% |
| ATXI | BUY | 2019-01-28 | 2019-01-30 | $5.90 | $110K | -7.5% | -14.0% | -21.5% |
| MBIO | BUY | 2018-11-23 | 2018-12-07 | $3.96 | $4K | -26.7% | -3.2% | +12.5% |
| ATXI | BUY | 2018-04-25 | 2018-04-25 | $3.80 | $4K | -0.3% | +0.3% | +4.4% |
| ATXI | BUY | 2017-10-17 | 2017-10-18 | $5.01 | $5K | -11.5% | -18.9% | -21.6% |
| ATXI | BUY | 2017-10-09 | 2017-10-10 | $5.24 | $3K | -14.5% | -7.3% | -29.3% |
| TGTX | BUY | 2012-12-06 | 2012-12-12 | $2.00 | $2K | -28.0% | -3.0% | -3.0% |
| IVPH.OB | BUY | 2007-04-24 | 2007-04-26 | $2.73 | $50K | N/A | N/A | N/A |
| MHA | BUY | 2007-03-30 | 2007-04-09 | $0.90 | $50K | N/A | N/A | N/A |
| MHA | BUY | 2006-07-10 | 2006-07-31 | $0.68 | $7K | N/A | N/A | N/A |
| MHA | BUY | 2006-01-10 | 2006-01-12 | $1.30 | $18K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| IVPH.OB |
| 25,252 |
| — |
| MHA | 77,288 | — |
| MHAN | 138,951 | — |
| Total | $6.0M |
Shares reported on the most recent Form 4, priced at the 2026-07-02 close. 4 holdings could not be priced and are excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.